Who owns the IP
The organizations most actively patenting around this compound, ranked by referenced patent volume.
| # | Assignee | Patents |
|---|---|---|
| 1 | Emory University | 224 |
| 2 | Gilead Sciences Inc | 92 |
| 3 | Arcus Biosciences Inc | 82 |
| 4 | Assembly Biosciences Inc | 64 |
| 5 | University of California, San Diego | 63 |
| 6 | ModernaTx Inc | 61 |
| 7 | Vitaeris Inc | 59 |
| 8 | Personalis Inc | 43 |
| 9 | Vertex Pharmaceuticals Inc | 43 |
| 10 | Shanghai Institute of Materia Medica | 37 |
Explore the full landscape
This preview shows the leading assignees. Cypris reveals the full ownership landscape - every filing entity, filing trends, and portfolio momentum.
Visit CyprisWhere innovation is concentrated
Patent classifications ranked by volume reveal the technical domains with the most active filing.
| # | Code | Area | Patents |
|---|---|---|---|
| 1 | A61K | Medicinal preparations | 3,107 |
| 2 | A61P | Therapeutic activity (drug indications) | 2,916 |
| 3 | C07K | Peptides | 976 |
| 4 | Y02A | Climate change adaptation | 883 |
| 5 | C12N | Microorganisms, enzymes | 757 |
| 6 | C07D | Heterocyclic compounds | 737 |
| 7 | G01N | Investigating / analysing materials | 409 |
| 8 | C07H | Sugars and derivatives | 291 |
| 9 | C12Q | Measuring/testing involving enzymes | 241 |
| 10 | C12Y | Enzyme nomenclature (EC numbers) | 172 |
AI mapped opportunity space
This preview shows where patent activity concentrates. Cypris maps the full classification landscape to surface technical whitespace and IP headroom.
See Cypris in actionMost-cited patents
Patents ranked by forward citations reveal the foundational inventions the field continues to build on.
| Title | Year | Assignee | Cited by |
|---|---|---|---|
| Intravenous administration preparation of arbidol and salt thereof and preparation method | 2006 | Hubei Huaheng Pharmaceutical Co.,Ltd. | 15 |
| A kind of preparation method of arbidol HCl | 2016 | Shandong Luo Xin Pharmaceutical Group Plc | 13 |
| Preparation method of arbidol hydrochloride | 2012 | HUBEI HUALONG BIOLOGICAL PHARMACEUTICAL CO., LTD. | 12 |
| Preparation method and quality control method of arbidol hydrochloride tablet | 2011 | WANG CHANGRUI | 12 |
| Arbidol dry suspension and preparation method thereof | 2011 | NORTHEAST PHARMACEUTICAL (SHENYANG) TECHNOLOGY DEVELOPMENT CO., LTD. | 11 |
Where research is gaining momentum
Research themes ranked by publication activity show where scientific interest is accelerating around this compound.
| # | Research topic | Papers |
|---|---|---|
| 1 | Influenza Virus Research Studies | 2 |
| 2 | Mosquito-borne diseases and control | 2 |
Who's driving the science
The most-published authors working with this compound, alongside their primary affiliations.
| # | Author | Affiliation | Papers |
|---|---|---|---|
| 1 | Burtseva Ei | D.I. Ivanovsky Institute of Virology Russian Academy of Medical Sciences | 9 |
| 2 | Eve‐Isabelle Pécheur | Lyon 1 Université | 9 |
| 3 | Irina A. Leneva | Research Institute of Vaccines and Sera. Mechnikov of the Russian Academy of Medical Sciences | 9 |
| 4 | Stephen J. Polyak | University of Washington | 6 |
| 5 | E. P. Selkova | Gabrichevsky Institute of Epidemiology and Microbiology | 5 |
| 6 | Hairong Xiong | Wuhan University | 4 |
| 7 | Leneva Ia | Federal State University of Education | 4 |
| 8 | A. N. Slepushkin | May Institute | 3 |
| 9 | Antonella Peduto | University of Salerno | 3 |
| 10 | Chen Chen | S.P.E.C.I.E.S. | 3 |
Research leaders
This preview lists the top authors. Cypris surfaces the full researcher landscape, their affiliations, and how scientific influence is shifting.
See Cypris in actionThe literature that defines it
The most-cited papers anchoring the scientific record for this compound.
| Title | Year | Cited by | Topic |
|---|---|---|---|
| The cytokine storm of severe influenza and development of immunomodulatory therapy | 2015 | 739 | Influenza Virus Research Studies |
| Clinical characteristics and therapeutic procedure for four cases with 2019 novel coronavirus pneumonia receiving combined Chinese and Western medicine treatment | 2020 | 577 | COVID-19 Clinical Research Studies |
| Arbidol combined with LPV/r versus LPV/r alone against Corona Virus Disease 2019: A retrospective cohort study | 2020 | 527 | COVID-19 Clinical Research Studies |
| Arbidol as a broad-spectrum antiviral: An update | 2014 | 497 | Influenza Virus Research Studies |
| Arbidol monotherapy is superior to lopinavir/ritonavir in treating COVID-19 | 2020 | 436 | COVID-19 Clinical Research Studies |
Frequently asked questions
Common questions about this compound's patent and research landscape, answered from the underlying data.
What is the molecular formula and weight of Arbidol?
How many patents and papers related to Arbidol are in the database?
Which organizations have published the most research on Arbidol?
What research topics are most associated with Arbidol studies?
What patent classification areas dominate Arbidol-related patents?